[
  {
    "date": "2022-12-30",
    "symbol": "CALA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "CALA",
    "entityregistrantname": "CALITHERA BIOSCIENCES, INC.",
    "entitycentralindexkey": 1496671,
    "currentfiscalyearenddate": "December 31",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "â˜’ ",
    "entityfilenumber": "001-36644",
    "entitytaxidentificationnumber": "27-2366329",
    "entityaddressaddressline1": "343 Oyster Point Blvd.",
    "entityaddressaddressline2": "Suite 200",
    "entityaddresscityortown": "South San Francisco",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94080,
    "cityareacode": 650,
    "localphonenumber": "870-1000",
    "entityincorporationstatecountrycode": "Delaware",
    "entityfilercategory": "Non-accelerated filer",
    "security12btitle": "Common Stock, Par Value $0.0001 Per Share",
    "securityexchangename": "The Nasdaq Global Select Market",
    "entityemerginggrowthcompany": "false",
    "entitysmallbusiness": "true",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "entityinteractivedatacurrent": "Yes",
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "San Mateo, California",
    "auditorfirmid": 42,
    "cashandcashequivalentsatcarryingvalue": 25451000,
    "prepaidexpenseandotherassetscurrent": 1173000,
    "assetscurrent": 26624000,
    "restrictedcashandcashequivalentsnoncurrent": 270000,
    "propertyplantandequipmentnet": 434000,
    "operatingleaserightofuseasset": 1348000,
    "assets": 28676000,
    "accountspayablecurrent": 732000,
    "accruedliabilitiesandotherliabilities": 6658000,
    "liabilitiescurrent": 7390000,
    "operatingleaseliabilitynoncurrent": 136000,
    "warrantliabilities": 758000,
    "liabilities": 8284000,
    "preferredstockvalue": 22300000,
    "additionalpaidincapitalcommonstock": 510666000,
    "retainedearningsaccumulateddeficit": -512616000,
    "stockholdersequity": -512616000,
    "liabilitiesandstockholdersequity": 28676000,
    "temporaryequityparorstatedvaluepershare": 0.0001,
    "temporaryequitysharesauthorized": 10000000,
    "temporaryequityliquidationpreference": 35000000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "preferredstocksharesissued": 1000000,
    "preferredstocksharesoutstanding": 1000000,
    "preferredstockliquidationpreferencevalue": 35000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 4868000,
    "commonstocksharesoutstanding": 4868000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2022#LicenseMember",
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 28533000,
    "generalandadministrativeexpense": 13541000,
    "operatingexpenses": 42074000,
    "operatingincomeloss": -42074000,
    "transactioncostsallocabletowarrantliabilities": 475000,
    "fairvalueadjustmentofwarrants": -2422000,
    "interestandotherincome": 477000,
    "othernonoperatingincomeexpense": 2424000,
    "netincomeloss": -39650000,
    "deemedcontributionfromseriesapreferredstockextinguishment": 18360000,
    "netincomelossavailabletocommonstockholdersbasic": -21290000,
    "earningspersharebasic": -4.6,
    "earningspersharediluted": -7.94,
    "weightedaveragenumberofsharesoutstandingbasic": 4633000,
    "weightedaveragenumberofdilutedsharesoutstanding": 4992000,
    "comprehensiveincomenetoftax": -39650000,
    "sharesoutstanding": 4868000,
    "reclassificationsoftemporarytopermanentequity": 40702000,
    "reclassificationsoftemporarytopermanentequityshares": 1000000,
    "stockissuedduringperiodvaluenewissues": 1137000,
    "stockissuedduringperiodsharesnewissues": 61690,
    "stockissuedduringperiodvaluesharebasedcompensation": 16000,
    "stockissuedduringperiodsharessharebasedcompensation": 23000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 4030000,
    "profitloss": -39650000,
    "depreciation": 255000,
    "sharebasedcompensation": 30000,
    "noncashleaseexpense": 1130000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -742000,
    "increasedecreaseinaccountspayable": -2918000,
    "increasedecreaseinaccruedliabilities": -3876000,
    "increasedecreaseinleaseliability": 1374000,
    "netcashprovidedbyusedinoperatingactivities": -43608000,
    "paymentstoacquirepropertyplantandequipment": 133000,
    "netcashprovidedbyusedininvestingactivities": -133000,
    "proceedsfromissuancesecondaryoffering": 8502000,
    "proceedsfromissuanceofcommonstock": 700000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 16000,
    "netcashprovidedbyusedinfinancingactivities": 9655000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -34086000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 25721000,
    "entityincorporationdateofincorporation": "March 9, 2010",
    "numberofoperatingsegments": 1,
    "stockholdersequityreversestocksplit": "On that date, every 20 issued and outstanding shares of the Company's common stock automatically converted into one outstanding share of common stock.",
    "availableforsalesecuritiesremainingcontractualmaturity": "one year or less",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "adopted",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2023",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "no",
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentestimatedusefullives": "Shorter of remaining lease term or estimated useful life",
    "weightedaveragemaximumblackscholescalculatedvaluepercentage": 1,
    "assetsfairvaluedisclosure": 25092000,
    "liabilitiesfairvaluedisclosure": 780000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0403,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 0.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.65,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 10.8,
    "shareprice": 3.26,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 780000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 25092000,
    "availableforsalesecuritiesdebtsecurities": 270000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 25700000,
    "cash": 600000,
    "cashequivalentsandrestrictedcash": 25100000,
    "depreciationdepletionandamortization": 300000,
    "propertyplantandequipmentgross": 3967000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 3533000,
    "accruedclinicalandmanufacturingexpensescurrent": 2315000,
    "employeerelatedliabilitiescurrent": 1794000,
    "operatingleaseliabilitycurrent": 1530000,
    "accruedpreclinicalandresearchexpensescurrent": 486000,
    "accruedprofessionalfeescurrent": 340000,
    "otheraccruedliabilitiescurrent": 193000,
    "lesseeoperatingleasedescription": "The Company has a non-cancelable facility lease agreement, or the Lease, for office and laboratory facilities in South San Francisco, California, with a remaining lease term of 1.1 years, through January 2024, and a two-year renewal option prior to expiration.",
    "operatingleaseweightedaverageremainingleaseterm1": 1.1,
    "lesseeoperatingleaserenewalterm": "two-year",
    "lesseesubleasedescription": "Company had a non-cancelable sublease agreement for a portion of its facilities through February 2020.",
    "letterofcreditsecuritydepositforleases": 270000,
    "operatingleasepayments": 1500000,
    "operatingleasecost": 1302000,
    "variableleasecost": 1125000,
    "leasecost": 2427000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities",
    "operatingleaseliability": 1666000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1593000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 136000,
    "lesseeoperatingleaseliabilitypaymentsdue": 1729000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 63000,
    "percentageofcommonstockbeneficialownershipinterestlimitation": 0.0999,
    "sharesissuedaveragepricepershare": 11.36,
    "proceedsreceiveduponsettlementoftrades": 451000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardgrantedperiod": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": 4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 456000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 50000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 40819,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 6.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 5400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 5.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 6.73,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 4300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumemployeesubscriptionrate": 0.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddiscountfrommarketpricepurchasedate": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 1000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 10.15,
    "allocatedsharebasedcompensationexpense": 6000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 1000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 18000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 158000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 118000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 272000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 456000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 88.24,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 8.25,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 105.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 127.45,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 88.24,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 14000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 4000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 53.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 58.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 56.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": 1.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 47000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 1.093,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 1.429,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0225,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0478,
    "definedcontributionplancostrecognized": 200000,
    "valuationallowancedeferredtaxassetchangeinamount": 9100000,
    "operatinglosscarryforwards": 279300000,
    "operatinglosscarryforwardsexpirationyear": 2030,
    "researchanddevelopmenttaxcreditcarryforwardsexpirationyear": 2030,
    "researchanddevelopmenttaxcreditcarryforward": 8000000,
    "unrecognizedtaxbenefits": 9100000,
    "taxcutsandjobsactcapitalizeddomesticexpensesamortizationperiod": "5-year",
    "taxcutsandjobsactcapitalizedforeignexpensesamortizationperiod": "15-year",
    "taxcutsandjobsactincreaseindeferredtaxassetsrelatedtocapitalizedresearchexpenses": 5100000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -39650000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -39650000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationtaxcredits": 0.033,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.011000000000000001,
    "effectiveincometaxratereconciliationchangeinfairvalueofwarrants": 0.013000000000000001,
    "effectiveincometaxratereconciliationotheradjustments": -0.013000000000000001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.23199999999999998,
    "deferredtaxassetsoperatinglosscarryforwards": 89381000,
    "deferredtaxassetstaxcreditcarryforwards": 15266000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 304000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 4562000,
    "deferredtaxassetsoperatingleaseliability": 350000,
    "deferredtaxassetsfixedandintangibleassets": 10217000,
    "deferredtaxassetsinprocessresearchanddevelopment": 5135000,
    "deferredtaxassetsgross": 125215000,
    "deferredtaxassetsvaluationallowance": 124932000,
    "deferredtaxassetsnet": 283000,
    "deferredtaxliabilitiesoperatingleaserightofuseasset": 283000,
    "deferredtaxliabilities": 283000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 5000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 707000,
    "dilutivesecuritieseffectonbasicearningspershareother": -18360000,
    "netincomelossavailabletocommonstockholdersdiluted": -39650000,
    "incrementalcommonsharesattributabletoconversionofpreferredstock": 359000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 2332000,
    "netcostspayabletocollaborationagreement": 100000,
    "netamountspayableundercollaborationagreement": 700000,
    "potentialdevelopmentandregulatorysalesmilestonemaximumpaymentreceivable": 252000000,
    "potentialdevelopmentandregulatorymilestonepayments": 23600000,
    "potentialsalesmilestones": 95000000
  },
  {
    "date": "2021-12-30",
    "symbol": "CALA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "CALA",
    "entityregistrantname": "CALITHERA BIOSCIENCES, INC.",
    "entitycentralindexkey": 1496671,
    "currentfiscalyearenddate": "December 31",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "true",
    "entityfilenumber": "001-36644",
    "entitytaxidentificationnumber": "27-2366329",
    "entityaddressaddressline1": "343 Oyster Point Blvd.",
    "entityaddressaddressline2": "Suite 200",
    "entityaddresscityortown": "South San Francisco",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94080,
    "cityareacode": 650,
    "localphonenumber": "870-1000",
    "entityincorporationstatecountrycode": "Delaware",
    "entityfilercategory": "Non-accelerated filer",
    "security12btitle": "Common Stock, Par Value $0.0001 Per Share",
    "securityexchangename": "The Nasdaq Global Select Market",
    "entityemerginggrowthcompany": "false",
    "entitysmallbusiness": "true",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "entityinteractivedatacurrent": "Yes",
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Redwood City, California",
    "auditorfirmid": 42,
    "cashandcashequivalentsatcarryingvalue": 59537000,
    "prepaidexpenseandotherassetscurrent": 1915000,
    "assetscurrent": 61452000,
    "restrictedcashandcashequivalentsnoncurrent": 270000,
    "propertyplantandequipmentnet": 556000,
    "operatingleaserightofuseasset": 2478000,
    "assets": 64756000,
    "accountspayablecurrent": 3650000,
    "accruedliabilitiesandotherliabilities": 10356000,
    "liabilitiescurrent": 14006000,
    "operatingleaseliabilitynoncurrent": 1666000,
    "liabilities": 15672000,
    "temporaryequitycarryingamountattributabletoparent": 40702000,
    "commonstockvalue": 8000,
    "additionalpaidincapitalcommonstock": 499700000,
    "retainedearningsaccumulateddeficit": -491326000,
    "stockholdersequity": -491326000,
    "liabilitiesandstockholdersequity": 64756000,
    "temporaryequityparorstatedvaluepershare": 0.0001,
    "temporaryequitysharesauthorized": 10000000,
    "temporaryequitysharesissued": 1000000,
    "temporaryequitysharesoutstanding": 1000000,
    "temporaryequityliquidationpreference": 35000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 77144000,
    "commonstocksharesoutstanding": 77144000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 9750000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2021-01-31#LicenseMember",
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 53455000,
    "researchanddevelopmentinprocess": 50875000,
    "generalandadministrativeexpense": 20853000,
    "operatingexpenses": 125183000,
    "operatingincomeloss": -115433000,
    "interestandotherincome": 345000,
    "netincomeloss": -115088000,
    "incomelossfromcontinuingoperationsperbasicanddilutedshare": -1.56,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 73869000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -3000,
    "comprehensiveincomenetoftax": -115091000,
    "sharesoutstanding": 77144000,
    "temporaryequitystockissuedduringperiodvaluenewissues": 40702000,
    "temporaryequitystockissuedduringperiodsharesnewissues": 1000000,
    "stockissuedduringperiodvaluenewissues": 10661000,
    "stockissuedduringperiodsharesnewissues": "null",
    "stockissuedduringperiodvaluesharebasedcompensation": 177000,
    "stockissuedduringperiodsharessharebasedcompensation": 1213000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 10264000,
    "temporaryequitystockissuancecosts": 173000,
    "profitloss": -115088000,
    "depreciation": 280000,
    "investmentincomenetamortizationofdiscountandpremium": -2000,
    "sharebasedcompensation": 159000,
    "gainlossonremeasurementofleaseliability": 362000,
    "noncashleaseexpense": 1134000,
    "seriesaconvertiblepreferredstockissuedforresearchanddevelopmentrelatedtoassetacquisition": 40875000,
    "increasedecreaseinaccountsreceivable": -1541000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -96000,
    "increasedecreaseinaccountspayable": 1656000,
    "increasedecreaseinaccruedliabilities": -5523000,
    "increasedecreaseinleaseliability": 1175000,
    "netcashprovidedbyusedinoperatingactivities": -66300000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 8000000,
    "paymentstoacquirepropertyplantandequipment": 147000,
    "netcashprovidedbyusedininvestingactivities": 7853000,
    "proceedsfromissuanceofcommonstock": 10700000,
    "paymentsofstockissuancecosts": 200000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 177000,
    "netcashprovidedbyusedinfinancingactivities": 10668000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -47779000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 59807000,
    "entityincorporationdateofincorporation": "March 9, 2010",
    "numberofoperatingsegments": 1,
    "availableforsalesecuritiesremainingcontractualmaturity": "one year or less",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "2019-12",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2021",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "no ",
    "changeinaccountingprincipleaccountingstandardsupdateearlyadoption": "early adopted",
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentestimatedusefullives": "Shorter of remaining lease term or estimated useful life",
    "assetsfairvaluedisclosure": 56337000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 56337000,
    "availableforsalesecuritiesdebtsecurities": 270000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 59800000,
    "cash": 3500000,
    "cashequivalentsandrestrictedcash": 56300000,
    "depreciationdepletionandamortization": 300000,
    "propertyplantandequipmentgross": 3850000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 3294000,
    "accruedclinicalandmanufacturingexpensescurrent": 5086000,
    "employeerelatedliabilitiescurrent": 3283000,
    "operatingleaseliabilitycurrent": 1374000,
    "otheraccruedliabilitiescurrent": 613000,
    "lesseeoperatingleasedescription": "The Company has a non-cancelable facility lease agreement, or the Lease, for office and laboratory facilities in South San Francisco, California, with a remaining lease term of 2.1 years, through January 2024, and a two-year renewal option prior to expiration.",
    "operatingleaseweightedaverageremainingleaseterm1": 2.1,
    "lesseeoperatingleaserenewalterm": "two-year",
    "lesseesubleasedescription": "Company had a non-cancelable sublease agreement for a portion of its facilities through February 2020.",
    "incrementalborrowingrate": 0.09,
    "letterofcreditsecuritydepositforleases": 270000,
    "gainrecognizedduetodifferencebetweenreducedleaseliabilityandreductioninoperatingleaserightofuseasset": 400000,
    "operatingleasepayments": 1500000,
    "operatingleasecost": 1461000,
    "variableleasecost": 1012000,
    "leasecost": 2473000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesAndOtherLiabilities",
    "operatingleaseliability": 3040000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1546000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1593000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 136000,
    "lesseeoperatingleaseliabilitypaymentsdue": 3275000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 235000,
    "equityfairvaluedisclosure": 40900000,
    "shareprice": 0.67,
    "sharesissuedpricepershare": 2.18,
    "grossproceedsfromissuanceofcommonstock": 11400000,
    "proceedsreceivablefromunsettledtrade": 451000,
    "commonstockremainedavailableforsale": 63600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardgrantedperiod": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": 4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 8324000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 1000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 680893,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 9400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 23000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 4.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 6.15,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 8900000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumemployeesubscriptionrate": 0.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddiscountfrommarketpricepurchasedate": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 2190000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.94,
    "allocatedsharebasedcompensationexpense": 3900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 3200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 1069000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2043000,
    "stockissuedduringperiodsharesstockoptionsexercised": 19000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 2337000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 5550000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 8324000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 6.18,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.86,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.81,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 6.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 7.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 6.18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 716000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 405000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 2.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 2.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 2.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": 1.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 477000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 0.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 1.031,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 1.266,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0004,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0011,
    "definedcontributionplancostrecognized": 300000,
    "valuationallowancedeferredtaxassetchangeinamount": 25100000,
    "operatinglosscarryforwards": 260399999.99999997,
    "operatinglosscarryforwardsexpirationyear": 2030,
    "taxcreditcarryforwardamount": 7400000,
    "unrecognizedtaxbenefits": 8400000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -115088000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -115088000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationtaxcredits": 0.018000000000000002,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.006,
    "effectiveincometaxratereconciliationotheradjustments": -0.003,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.219,
    "deferredtaxassetsoperatinglosscarryforwards": 85417000,
    "deferredtaxassetstaxcreditcarryforwards": 13965000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 678000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 4904000,
    "deferredtaxassetsoperatingleaseliability": 638000,
    "deferredtaxassetsfixedandintangibleassets": 10765000,
    "deferredtaxassetsgross": 116367000,
    "deferredtaxassetsvaluationallowance": 115847000,
    "deferredtaxassetsnet": 520000,
    "deferredtaxliabilitiesoperatingleaserightofuseasset": 520000,
    "deferredtaxliabilities": 520000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1129000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 26238000,
    "potentialdevelopmentandregulatoryandcommercializationmilestonemaximumpaymentreceivable": 720000000,
    "contractwithcustomerliabilityrevenuerecognized": 57000000,
    "collaborationagreementtransactionprice": 57000000,
    "upfrontconsiderationallocatedtocombinedunitofaccounting": 3000000,
    "developmentmilestonerecognized": 12000000,
    "netcostspayabletocollaborationagreement": 54000,
    "potentialdevelopmentandregulatorysalesmilestonemaximumpaymentreceivable": 252000000,
    "severancecosts1": 200000,
    "restructuringcharges": 1156000,
    "paymentsforrestructuring": 1156000
  },
  {
    "date": "2020-12-30",
    "symbol": "CALA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "DecemberÂ 31, 2020",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "CALA",
    "entityregistrantname": "CALITHERA BIOSCIENCES, INC.",
    "entitycentralindexkey": 1496671,
    "currentfiscalyearenddate": "--12-31",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilenumber": "001-36644",
    "entitytaxidentificationnumber": "27-2366329",
    "entityaddressaddressline1": "343 Oyster Point Blvd.",
    "entityaddressaddressline2": "Suite 200",
    "entityaddresscityortown": "South San Francisco",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94080,
    "cityareacode": 650,
    "localphonenumber": "870-1000",
    "entityincorporationstatecountrycode": "Delaware",
    "entityfilercategory": "Non-acceleratedÂ filer",
    "security12btitle": "Common Stock, Par Value $0.0001 Per Share",
    "securityexchangename": "The Nasdaq Global Select Market",
    "entityemerginggrowthcompany": "false",
    "entitysmallbusiness": "true",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "entityinteractivedatacurrent": "Yes",
    "cashandcashequivalentsatcarryingvalue": 107146000,
    "availableforsalesecuritiescurrent": 8005000,
    "accountsreceivablenetcurrent": 900000,
    "prepaidexpenseandotherassetscurrent": 2011000,
    "assetscurrent": 118703000,
    "restrictedcashandcashequivalentsnoncurrent": 440000,
    "propertyplantandequipmentnet": 690000,
    "operatingleaserightofuseasset": 5754000,
    "assets": 125587000,
    "accountspayablecurrent": 1994000,
    "accruedliabilitiesandotherliabilities": 16407000,
    "liabilitiescurrent": 18401000,
    "operatingleaseliabilitynoncurrent": 4815000,
    "liabilities": 23216000,
    "commonstockvalue": 7000,
    "additionalpaidincapitalcommonstock": 478599000,
    "retainedearningsaccumulateddeficit": -376238000,
    "accumulatedothercomprehensiveincomelossnetoftax": 3000,
    "stockholdersequity": 3000,
    "liabilitiesandstockholdersequity": 125587000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 70686000,
    "commonstocksharesoutstanding": 70686000,
    "typeofrevenueextensiblelist": "us-gaap:LicenseAndServiceMember",
    "researchanddevelopmentexpense": 71015000,
    "generalandadministrativeexpense": 20372000,
    "operatingexpenses": 91387000,
    "operatingincomeloss": -91387000,
    "interestandotherincome": 1250000,
    "netincomeloss": -90137000,
    "incomelossfromcontinuingoperationsperbasicanddilutedshare": -1.31,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 68814000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -39000,
    "comprehensiveincomenetoftax": -90176000,
    "sharesoutstanding": 70686000,
    "stockissuedduringperiodvaluenewissues": 7397000,
    "stockissuedduringperiodsharesnewissues": 1160000,
    "stockissuedduringperiodvaluestockoptionsexercised": 407000,
    "stockissuedduringperiodsharesstockoptionsexercised": 64000,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 793000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 198000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 8060000,
    "profitloss": -90137000,
    "depreciation": 364000,
    "investmentincomenetamortizationofdiscountandpremium": 142000,
    "sharebasedcompensation": 451000,
    "noncashleaseexpense": 1506000,
    "increasedecreaseinaccountsreceivable": 1059000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 58000,
    "increasedecreaseinotheroperatingassets": -280000,
    "increasedecreaseinaccountspayable": -58000,
    "increasedecreaseinaccruedliabilities": -1590000,
    "increasedecreaseinleaseliability": 1478000,
    "netcashprovidedbyusedinoperatingactivities": -84312000,
    "paymentstoacquireavailableforsalesecurities": 57059000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 146080000,
    "paymentstoacquirepropertyplantandequipment": 61000,
    "netcashprovidedbyusedininvestingactivities": 88960000,
    "proceedsfromissuancesecondaryoffering": 33464000,
    "proceedsfromissuanceofcommonstock": 7397000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 1200000,
    "netcashprovidedbyusedinfinancingactivities": 42061000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 46709000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 107586000,
    "entityincorporationdateofincorporation": "March 9, 2010",
    "numberofoperatingsegments": 1,
    "numberofproductscoveredundercollaborationandlicensingagreement": 1,
    "collaborationagreementtransactionprice": 57000000,
    "upfrontpaymentreceived": 45000000,
    "developmentmilestoneachieved": 12000000,
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentestimatedusefullives": "Shorter of remaining lease term or estimated useful life",
    "assetsfairvaluedisclosure": 114787000,
    "availableforsalesecuritiesamortizedcost": 114784000,
    "availableforsalesecuritiesaccumulatedgrossunrealizedgainbeforetax": 3000,
    "availableforsalesecurities": 440000,
    "availableforsalesecuritiesremainingcontractualmaturity": "less than one year",
    "cashcashequivalentsrestrictedcashandinvestments": 115600000,
    "cash": 800000,
    "cashequivalentsrestrictedcashandinvestments": 114800000,
    "depreciationdepletionandamortization": 364000,
    "propertyplantandequipmentgross": 4103000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 3413000,
    "accruedclinicalandmanufacturingexpensescurrent": 7910000,
    "employeerelatedliabilitiescurrent": 5142000,
    "operatingleaseliabilitycurrent": 1903000,
    "otheraccruedliabilitiescurrent": 1452000,
    "lesseeoperatingleasedescription": "The Company has a non-cancelable facility lease agreement, or the Lease, for office and laboratory facilities in South San Francisco, California, with a remaining lease term of 3.1 years, through January 2024, and a two-year renewal option prior to expiration.",
    "operatingleaseweightedaverageremainingleaseterm1": 3.1,
    "lesseeoperatingleaserenewalterm": "P2Y",
    "lesseesubleasedescription": "Company had a non-cancelable sublease agreement for a portion of its facilities through February 2020.",
    "incrementalborrowingrate": 0.09,
    "operatingleasepayments": 2100000,
    "letterofcreditsecuritydepositforlease": 440000,
    "operatingleasecost": 2177000,
    "variableleasecost": 1509000,
    "subleaseincome": 187000,
    "variablesubleaseincome": 93000,
    "leasecost": 3406000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "us-gaap:AccruedLiabilitiesAndOtherLiabilities",
    "operatingleaseliability": 6718000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 2413000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 2485000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 2559000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 219000,
    "lesseeoperatingleaseliabilitypaymentsdue": 7676000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 958000,
    "operatingleasesrentexpenseminimumrentals": 3686000,
    "operatingleasesrentexpensesubleaserentals1": 280000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardgrantedperiod": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 8637000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 1000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 556128,
    "shareprice": 4.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 6900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 5.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 6.4,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 14600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.53,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumemployeesubscriptionrate": 0.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddiscountfrommarketpricepurchasedate": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 960522,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2617000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 429000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4979000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 8637000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 6.91,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 6.88,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 3.1,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 7.24,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 6.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 2758000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 2232000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 2758000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.543,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 1.255,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0008,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0159,
    "definedcontributionplancostrecognized": 400000,
    "valuationallowancedeferredtaxassetchangeinamount": 20600000,
    "operatinglosscarryforwards": 203200000,
    "operatinglosscarryforwardsexpirationyear": 2030,
    "taxcreditcarryforwardamount": 6300000,
    "unrecognizedtaxbenefits": 7300000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -90137000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -90137000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationtaxcredits": 0.027000000000000003,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.006999999999999999,
    "effectiveincometaxratereconciliationotheradjustments": -0.001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.22899999999999998,
    "deferredtaxassetsoperatinglosscarryforwards": 73405000,
    "deferredtaxassetstaxcreditcarryforwards": 11874000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 948000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 4091000,
    "deferredtaxassetsoperatingleaseliability": 1411000,
    "deferredtaxassetsother": 277000,
    "deferredtaxassetsgross": 92006000,
    "deferredtaxassetsvaluationallowance": 90797000,
    "deferredtaxassetsnet": 1209000,
    "deferredtaxliabilitiesoperatingleaserightofuseasset": 1209000,
    "deferredtaxliabilities": 1209000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 24000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1303000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 8658000,
    "upfrontconsiderationallocatedtocombinedunitofaccounting": 45000000,
    "developmentmilestonerecognized": 12000000,
    "increasedecreaseinresearchanddevelopmentexpenses": 8000,
    "decreaseinresearchanddevelopmentexpense": 1500000,
    "potentialdevelopmentandregulatorymilestonepayments": 23600000,
    "potentialsalesmilestones": 95000000,
    "reductionofresearchanddevelopmentexpense": 600000
  },
  {
    "date": "2019-12-30",
    "symbol": "CALA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "CALA",
    "entityregistrantname": "CALITHERA BIOSCIENCES, INC.",
    "entitycentralindexkey": 1496671,
    "currentfiscalyearenddate": "--12-31",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilenumber": "001-36644",
    "entitytaxidentificationnumber": 272366329,
    "entityaddressaddressline1": "343 Oyster Point Blvd.",
    "entityaddressaddressline2": "Suite 200",
    "entityaddresscityortown": "South San Francisco",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94080,
    "cityareacode": 650,
    "localphonenumber": "870-1000",
    "entityfilercategory": "Accelerated Filer",
    "entityemerginggrowthcompany": "false",
    "entitysmallbusiness": "true",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "cashandcashequivalentsatcarryingvalue": 60437000,
    "availableforsalesecuritiescurrent": 96924000,
    "accountsreceivablenetcurrent": 500000,
    "prepaidexpenseandotherassetscurrent": 1953000,
    "assetscurrent": 159796000,
    "otherassetsnoncurrent": 280000,
    "restrictedcashandcashequivalentsnoncurrent": 440000,
    "propertyplantandequipmentnet": 992000,
    "operatingleaserightofuseasset": 8600000,
    "assets": 168768000,
    "accountspayablecurrent": 2052000,
    "accruedliabilitiesandotherliabilities": 17572000,
    "liabilitiescurrent": 19624000,
    "operatingleaseliabilitynoncurrent": 6718000,
    "deferredrentcreditnoncurrent": 1200000,
    "liabilities": 26342000,
    "commonstockvalue": 6000,
    "additionalpaidincapitalcommonstock": 428479000,
    "retainedearningsaccumulateddeficit": -286101000,
    "accumulatedothercomprehensiveincomelossnetoftax": 42000,
    "stockholdersequity": 42000,
    "liabilitiesandstockholdersequity": 168768000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 63514000,
    "commonstocksharesoutstanding": 63514000,
    "typeofrevenueextensiblelist": "us-gaap:LicenseAndServiceMember",
    "researchanddevelopmentexpense": 76290000,
    "generalandadministrativeexpense": 16605000,
    "operatingexpenses": 92895000,
    "operatingincomeloss": -92895000,
    "interestandotherincome": 3035000,
    "netincomeloss": -89860000,
    "incomelossfromcontinuingoperationsperbasicanddilutedshare": -1.9,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 47312000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 155000,
    "comprehensiveincomenetoftax": -89705000,
    "sharesoutstanding": 63514000,
    "stockissuedduringperiodvaluenewissues": 43968000,
    "stockissuedduringperiodsharesnewissues": 9929742,
    "stockissuedduringperiodvaluestockoptionsexercised": 490000,
    "stockissuedduringperiodsharesstockoptionsexercised": 191000,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 732000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 185000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 6466000,
    "cumulativeeffectonretainedearningsnetoftax1": -71000,
    "profitloss": -89860000,
    "depreciation": 479000,
    "investmentincomenetamortizationofdiscountandpremium": 897000,
    "sharebasedcompensation": 357000,
    "noncashleaseexpense": 1366000,
    "increasedecreaseinaccountsreceivable": -1515000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 26000,
    "increasedecreaseinotheroperatingassets": -289000,
    "increasedecreaseinaccountspayable": 816000,
    "increasedecreaseinaccruedliabilities": 2576000,
    "increasedecreaseinleaseliability": 1469000,
    "netcashprovidedbyusedinoperatingactivities": -78745000,
    "paymentstoacquireavailableforsalesecurities": 153227000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 142450000,
    "paymentstoacquirepropertyplantandequipment": 7000,
    "netcashprovidedbyusedininvestingactivities": -10784000,
    "proceedsfromissuancesecondaryoffering": 53760000,
    "proceedsfromissuanceofcommonstock": 44000000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 1222000,
    "netcashprovidedbyusedinfinancingactivities": 98908000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 9379000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 60877000,
    "unpaidamountsrelatedtodeferredfinancingcosts": 68000,
    "entityincorporationstatecountryname": "Delaware",
    "entityincorporationdateofincorporation": "2010-03-09",
    "numberofoperatingsegments": 1,
    "numberofproductscoveredundercollaborationandlicensingagreement": 1,
    "collaborationagreementtransactionprice": 57000000,
    "upfrontpaymentreceived": 45000000,
    "developmentmilestoneachieved": 12000000,
    "operatingleaseliability": 8196000,
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentestimatedusefullives": "Shorter of remaining lease term or estimated useful life",
    "assetsfairvaluedisclosure": 156855000,
    "availableforsalesecuritiesamortizedcost": 156813000,
    "availableforsalesecuritiesaccumulatedgrossunrealizedgainbeforetax": 46000,
    "availableforsalesecuritiesaccumulatedgrossunrealizedlossbeforetax": 4000,
    "availableforsalesecurities": 440000,
    "availableforsalesecuritiesremainingcontractualmaturity": "less than one year",
    "cashcashequivalentsrestrictedcashandinvestments": 157800000,
    "cash": 900000,
    "cashequivalentsrestrictedcashandinvestments": 156900000,
    "depreciationdepletionandamortization": 479000,
    "propertyplantandequipmentgross": 4194000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 3202000,
    "accruedclinicalandmanufacturingexpensescurrent": 8270000,
    "employeerelatedliabilitiescurrent": 5045000,
    "collaborationreimbursementadvances": 1547000,
    "operatingleaseliabilitycurrent": 1478000,
    "otheraccruedliabilitiescurrent": 1232000,
    "accruedliabilitiescurrent": 17572000,
    "lesseeoperatingleasedescription": "The Company has a non-cancelable facility lease agreement, or the Lease, for office and laboratory facilities in South San Francisco, California, with a remaining lease term of 4.09 years, through January 2024, and a two-year renewal option prior to expiration.",
    "operatingleaseweightedaverageremainingleaseterm1": "P4Y1M2D",
    "lesseeoperatingleaserenewalterm": "P2Y",
    "lesseesubleasedescription": "Company has a non-cancelable sublease agreement for a portion of its facilities through February 2020.",
    "incrementalborrowingrate": 0.09,
    "operatingleasepayments": 2300000,
    "letterofcreditsecuritydepositforlease": 440000,
    "operatingleasecost": 2177000,
    "variableleasecost": 1327000,
    "subleaseincome": 1115000,
    "variablesubleaseincome": 509000,
    "leasecost": 1880000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "us-gaap:AccruedLiabilitiesAndOtherLiabilities",
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 2148000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 2413000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 2485000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 2559000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 219000,
    "lesseeoperatingleaseliabilitypaymentsdue": 9824000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 1628000,
    "operatingleasesrentexpenseminimumrentals": 3504000,
    "operatingleasesrentexpensesubleaserentals1": 1624000,
    "registrationpaymentarrangementmaximumpotentialconsideration": 50000000,
    "percentageofcommissiontosalesagent": 0.03,
    "sharesissuedpricepershare": 4.54,
    "grossproceedsfromissuanceofcommonstock": 45100000,
    "commonstockcapitalsharesvaluereservedforfutureissuance": 7600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardgrantedperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 6513000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 1000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 503120,
    "shareprice": 5.71,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 6700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y11M19D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y2M23D",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 10700000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y6M14D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumemployeesubscriptionrate": 0.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddiscountfrommarketpricepurchasedate": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 763530,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2222000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 187000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 3525000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 6513000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 6.89,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 4.75,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 3.67,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 8.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 7.89,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 6.89,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 5808000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 3203000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 5808000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.529,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.82,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0158,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0255,
    "definedcontributionplancostrecognized": 300000,
    "valuationallowancedeferredtaxassetchangeinamount": 20700000,
    "operatinglosscarryforwards": 118100000,
    "operatinglosscarryforwardsexpirationyear": 2030,
    "taxcreditcarryforwardamount": 5100000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "unrecognizedtaxbenefits": 5993000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -89860000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -89860000,
    "effectiveincometaxratereconciliationtaxcredits": 0.025,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.004,
    "effectiveincometaxratereconciliationotheradjustments": -0.001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.23,
    "deferredtaxassetsoperatinglosscarryforwards": 55531000,
    "deferredtaxassetstaxcreditcarryforwards": 9514000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 1600000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 3070000,
    "deferredtaxassetsoperatingleaseliability": 1721000,
    "deferredtaxassetsother": 279000,
    "deferredtaxassetsgross": 71715000,
    "deferredtaxassetsvaluationallowance": 70190000,
    "deferredtaxassetsnet": 1525000,
    "deferredtaxliabilitiesoperatingleaserightofuseasset": 1525000,
    "deferredtaxliabilities": 1525000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 6000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1035000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 6532000,
    "potentialdevelopmentandregulatorysalesmilestonemaximumpaymentreceivable": 418000000,
    "upfrontconsiderationallocatedtocombinedunitofaccounting": 45000000,
    "developmentmilestonerecognized": 12000000,
    "increasedecreaseinresearchanddevelopmentexpenses": -200000,
    "potentialdevelopmentandregulatorymilestonepayments": 23600000,
    "potentialsalesmilestones": 95000000
  },
  {
    "date": "2018-12-30",
    "symbol": "CALA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2018-12-31",
    "documentfiscalyearfocus": 2018,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "CALA",
    "entityregistrantname": "Calithera Biosciences, Inc.",
    "entitycentralindexkey": 1496671,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "cashandcashequivalentsatcarryingvalue": 51058000,
    "availableforsalesecuritiescurrent": 85095000,
    "accountsreceivablenetcurrent": 2000000,
    "prepaidexpenseandotherassetscurrent": 2102000,
    "assetscurrent": 140252000,
    "otherassetsnoncurrent": 569000,
    "restrictedcashandcashequivalentsnoncurrent": 440000,
    "propertyplantandequipmentnet": 1464000,
    "assets": 142725000,
    "accountspayablecurrent": 1247000,
    "accruedliabilitiescurrent": 13634000,
    "liabilitiescurrent": 14881000,
    "deferredrentcreditnoncurrent": 1130000,
    "liabilities": 16011000,
    "commonstockvalue": 4000,
    "additionalpaidincapitalcommonstock": 322993000,
    "retainedearningsaccumulateddeficit": -196170000,
    "accumulatedothercomprehensiveincomelossnetoftax": -113000,
    "stockholdersequity": -113000,
    "liabilitiesandstockholdersequity": 142725000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 38834000,
    "commonstocksharesoutstanding": 38834000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 31046000,
    "typeofrevenueextensiblelist": "us-gaap:LicenseAndServiceMember",
    "researchanddevelopmentexpense": 66195000,
    "generalandadministrativeexpense": 13340000,
    "operatingexpenses": 79535000,
    "operatingincomeloss": -48489000,
    "interestincomeexpensenet": 2652000,
    "netincomeloss": -45837000,
    "incomelossfromcontinuingoperationsperbasicanddilutedshare": -1.49,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 36604000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 157000,
    "comprehensiveincomenetoftax": -54472000,
    "sharesoutstanding": 38834000,
    "stockissuedduringperiodvaluenewissues": 13729000,
    "stockissuedduringperiodsharesnewissues": 2730789,
    "stockissuedduringperiodvaluestockoptionsexercised": 247000,
    "stockissuedduringperiodsharesstockoptionsexercised": 125000,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 674000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 219000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 7437000,
    "cumulativeeffectonretainedearningsnetoftax1": 8792000,
    "profitloss": -54629000,
    "depreciation": 505000,
    "investmentincomenetamortizationofdiscountandpremium": 272000,
    "sharebasedcompensation": 1017000,
    "increasedecreaseinaccountsreceivable": 855000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -630000,
    "increasedecreaseinotheroperatingassets": 341000,
    "increasedecreaseinaccountspayable": 175000,
    "increasedecreaseinaccruedliabilities": 4725000,
    "increasedecreaseincontractwithcustomerliability": -22254000,
    "increasedecreaseindeferredrent": 37000,
    "netcashprovidedbyusedinoperatingactivities": -64842000,
    "paymentstoacquireavailableforsalesecurities": 76107000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 129120000,
    "paymentstoacquirepropertyplantandequipment": 214000,
    "netcashprovidedbyusedininvestingactivities": 52799000,
    "proceedsfromissuanceofcommonstock": 13700000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 921000,
    "netcashprovidedbyusedinfinancingactivities": 14626000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 2583000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 51498000,
    "changeincapitalexpendituresincurredbutnotyetpaid": -5000,
    "changeinunpaidamountsrelatedtodeferredfinancingcosts": 24000,
    "entityincorporationstatecountryname": "Delaware",
    "entityincorporationdateofincorporation": "2017-04-20",
    "numberofoperatingsegments": 1,
    "numberofproductscoveredundercollaborationandlicensingagreement": 1,
    "collaborationagreementtransactionprice": 57000000,
    "upfrontpaymentreceived": 45000000,
    "developmentmilestoneachieved": 12000000,
    "increasedecreaseincontractliabilities": -31000000,
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentestimatedusefullives": "Shorter of remaining lease term or estimated useful life",
    "assetsfairvaluedisclosure": 136216000,
    "availableforsalesecuritiesamortizedcost": 136329000,
    "availableforsalesecuritiesaccumulatedgrossunrealizedgainbeforetax": 4000,
    "availableforsalesecuritiesaccumulatedgrossunrealizedlossbeforetax": 117000,
    "availableforsalesecurities": 440000,
    "availableforsalesecuritiesremainingcontractualmaturity": "less than one year",
    "availableforsalesecuritiesunrealizedlossesoncashequivalentsandinvestments": 100000,
    "availableforsalesecuritiesunrealizedlossoninvestmentsinacontinuouslosspositionfortwelvemonthsorlonger": 59000,
    "availableforsalesecuritiesunrealizedlossesfairvalueinacontinuouslosspositionfortwelvemonthsorlonger": 22400000,
    "cashcashequivalentsrestrictedcashandinvestments": 136600000,
    "cash": 400000,
    "cashequivalentsrestrictedcashandinvestments": 136200000,
    "depreciationdepletionandamortization": 505000,
    "propertyplantandequipmentgross": 4208000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 2744000,
    "accruedclinicalandmanufacturingexpenses": 6316000,
    "employeerelatedliabilitiescurrent": 3529000,
    "collaborationreimbursementadvances": 2467000,
    "accruedprofessionalfeescurrent": 581000,
    "accruedpreclinicalandresearchexpenses": 359000,
    "otheraccruedliabilitiescurrent": 382000,
    "operatingleasesfutureminimumpaymentsduecurrent": 2260000,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 2342000,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 2413000,
    "operatingleasesfutureminimumpaymentsdueinfouryears": 2485000,
    "operatingleasesfutureminimumpaymentsduethereafter": 2779000,
    "operatingleasesfutureminimumpaymentsdue": 12279000,
    "operatingleasesfutureminimumpaymentsduefutureminimumsubleaserentalsduecurrent": 1115000,
    "operatingleasesfutureminimumpaymentsduefutureminimumsubleaserentalsdueintwoyears": 187000,
    "operatingleasesfutureminimumpaymentsduefutureminimumsubleaserentals": 1302000,
    "operatingleasesrentexpenseminimumrentals": 3439000,
    "operatingleasesrentexpensesubleaserentals1": 1566000,
    "sharesissuedpricepershare": 5.18,
    "grossproceedsfromissuanceofcommonstock": 14200000,
    "commonstockcapitalsharesvaluereservedforfutureissuance": 34200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardgrantedperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 4669000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 4700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 437904,
    "shareprice": 4.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.69,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 5600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y9M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y6M14D",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 9900000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y4M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumemployeesubscriptionrate": 0.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddiscountfrommarketpricepurchasedate": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 578746,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1304000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 81000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2517000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 4669000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 7.86,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 7.83,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.97,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 8.19,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 8.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 7.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 1108000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 824000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 1108000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P10M9D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.866,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0156,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0255,
    "valuationallowancedeferredtaxassetchangeinamount": 11300000,
    "operatinglosscarryforwards": 53600000,
    "taxcreditcarryforwardamount": 4300000,
    "operatinglosscarryforwardsexpirationyear": 2030,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "unrecognizedtaxbenefits": 4964000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -54629000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -54629000,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.007,
    "effectiveincometaxratereconciliationtaxcredits": 0.044,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.014,
    "effectiveincometaxratereconciliationotheradjustments": -0.001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.246,
    "deferredtaxassetsoperatinglosscarryforwards": 38707000,
    "deferredtaxassetstaxcreditcarryforwards": 7220000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 1109000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2152000,
    "deferredtaxassetsother": 273000,
    "deferredtaxassetsgross": 49461000,
    "deferredtaxassetsvaluationallowance": 49461000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1341000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 4685000,
    "potentialdevelopmentandregulatorysalesmilestonemaximumpaymentreceivable": 418000000,
    "futurenetprofitlosssharepercentage": 0.6,
    "profitandlosssharingdescription": "Incyte and the Company will share in any future United States net profits and losses, with the Company bearing 40% and Incyte bearing 60%, respectively, and outside the United States the Company will be eligible to receive from Incyte tiered royalties, with rates in the low to mid-teens of sales.",
    "upfrontconsiderationallocatedtocombinedunitofaccounting": 45000000,
    "developmentmilestonerecognized": 12000000,
    "contractwithcustomerliabilityrevenuerecognized": 22200000,
    "reductioninresearchanddevelopmentexpenses": 3900000,
    "potentialdevelopmentandregulatorymilestonepayments": 23600000,
    "potentialsalesmilestones": 95000000
  }
]